Condition
Stress Disorders, Traumatic, Acute
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 2 (1)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04785677Not ApplicableCompleted
Researching Resiliency in Stressful Experiences (RISE) Program for Men Leaving Incarceration
NCT04071600Phase 1Unknown
Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder
NCT03438175Not ApplicableUnknown
Intensiva 2.0: Improve the Communication Towards Families of Critically Ill Patients
NCT01200628Completed
DEPITAC : Short Screening Scale for Psychotraumatic Disorders After Motor Vehicle Accident
NCT00069355Phase 2CompletedPrimary
Propranolol for the Treatment of Acute Stress Disorder
Showing all 5 trials